Почетна › Рак простате › Орегон
Kliničke studije za Рак простате u državi Орегон
38 studija za Рак простате traži učesnike na lokacijama u državi Орегон.
Gradovi u državi Орегон
Zvanični tekst studije (na engleskom)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Providence Newberg Medical Center, Newberg
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Willamette Falls Medical Center, Oregon City
- и још 3
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
Тражи се учесникФаза 4
Узраст 18 и старији · Мушкарци · Ажурирано 5. 11. 2026. · NCT07569926cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 40 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- и још 7
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06632977A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06095089Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT07200830A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 30. 10. 2026. · NCT06925737A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 26. 10. 2026. · NCT05593497Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
Тражи се учесникОпсервациона студија
Узраст од 18 до 120 · Мушкарци · Ажурирано 26. 10. 2026. · NCT04706663Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 19. 10. 2026. · NCT07611110A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 16. 10. 2026. · NCT06879041Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Portland
- Research Site, Portland
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 15. 10. 2026. · NCT07711002Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
Тражи се учесникФаза 1/2
Узраст од 18 до 99 · Мушкарци · Ажурирано 14. 10. 2026. · NCT07590934A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT06952803EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06049355FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 24. 9. 2026. · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
Тражи се учесникФаза 2/3
Узраст од 18 до 100 · Мушкарци · Ажурирано 22. 9. 2026. · NCT06780670High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT04038502Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 11. 9. 2026. · NCT06056830A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 31. 8. 2026. · NCT05726292Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- и још 8
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 7. 2026. · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 25. 6. 2026. · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 15. 6. 2026. · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
Тражи се учесникОпсервациона студија
Узраст 21 и старији · Мушкарци · Ажурирано 22. 5. 2026. · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 40 и старији · Мушкарци · Ажурирано 15. 5. 2026. · NCT04472338Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 8. 5. 2026. · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
Тражи се учесник
Узраст 65 и старији · Мушкарци · Ажурирано 6. 5. 2026. · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- и још 9
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 29. 1. 2026. · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 22. 1. 2026. · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 20. 4. 2022. · NCT03753243Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.